• Blog
  • Nebulizer Devices Market Size & Share Analysis

    Nebulizer Devices Market Size & Share Analysis

    Nebulizer Devices Market Size & Share Analysis
    Report code - SRHL253 Delivery - 2 Weeks
    Nebulizer Devices Market Size, Share, Dynamics, & Forecast Analysis- 2023-2028.
    See more...

    Market Insights

    The nebulizer devices market was estimated at USD 1.13 billion in 2022 and is likely to grow at a CAGR of 6% during 2023-2028 to reach USD 1.62 billion in 2028.

    Nebulizer-Devices-Market-Insights

    Want to know more about the market scope? Register Here

    What are nebulizer devices?

    Nebulizers are respiratory drug delivery therapeutic device that helps to transform liquid drug into aerosols or mist and delivers them directly to the lungs. The nebulization technique is commonly used to treat respiratory diseases such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). These devices are electrically powered and rechargeable. Nebulizers are specifically used to deliver liquid medication to breathing passage, thus reducing the bulging of the mucous membrane caused by pollutants.

    Nebulizer Devices Market Highlights

    Market Size in 2022

    USD 1.13 billion

    Market Size in 2028

    USD 1.62 billion

    Market Growth (2023-2028)

    6% CAGR

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Key Players

    Key players operating in the nebulizer devices market are-

    • Agilent Technologies, Inc. (The U.S),
    • Allied Healthcare Products, Inc. (The U.S),
    • CareFusion Corporation (The U.S),
    • Covidien plc (Ireland),
    • GE Healthcare (The U.S),
    • GF Health Products Inc. (The U.S),
    • Omron Healthcare, Inc. (Japan),
    • PARI GmbH (Germany),
    • Koninklijke Philips N.V. (Netherlands), and
    • Briggs Healthcare (The U.S).

    Market Dynamics

    A rise in environmental pollution and a surge in the number of smokers propel the need for nebulizer devices.

    • The rising of chronic respiratory diseases, the growing geriatric population, and increasing demand for home-based healthcare devices are some of the factors boosting the nebulizer devices market growth.
    • Also, increasing consumption of tobacco, alcohol, and ultra-processed products such as sugar-sweetened beverages is one of the prime causes behind the rising prevalence of respiratory diseases, especially in North America.
    • Furthermore, according to WHO, there were around 3.2 million deaths across the globe due to COPD.

    Nebulizer-Devices-Market-Dynamics

    Want to have a closer look at this market report? Click Here

    Segment Analysis

    Type Trends

    Based on type, the nebulizer devices market has been categorized into jet, ultrasound, and mesh.

    • Under these, the jet segment held a considerable market share in 2022 and is likely to grow at the fastest CAGR during the forecast period.
    • This is mainly attributed to the technologically advanced compact size devices and minimized drug loss, thus enhancing the effectiveness of the nebulizer devices.
    • Other factors such as portability, quick treatment, increased patient acceptance, and convenience bolster the market expansion.

    Regional Trends

    By region, the North American market garnered the highest market share of more than 25% in 2022 and is projected to grow at a steady CAGR during the assessment period.

    This is mainly attributed to the rising respiratory disorders, well-established healthcare infrastructure, rise in customer awareness, and government initiatives such as favorable reimbursement scenario, which further accelerates the regional market growth.

    Nebulizer-Devices-Market-Regional-Trends

    Know which region offers the best growth opportunities. Register Here

    COVID-19 Impact on the Nebulizer Devices Market

    The unprecedented outbreak of COVID-19 resulted in surging demand for mechanical ventilators, thus creating a substantial shortage of these devices in major COVID-19-affected countries.

    The unmet demand for mechanical ventilators is encouraging medical professionals to shift towards other respirator devices such as nebulizers and oxygen concentrators. Thus, this is a key factor positively influencing product demand in the present period.

    Critical Questions Answered in the Report

    • What are the key trends in the market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Target Audience

    Here is the list of the group of customers that the nebulizer devices market hopes to have the greatest opportunity to convert-

    • Nebulizer devices companies
    • Hospitals
    • R&D organizations
    • Respiratory devices manufacturing companies
    • Government organizations

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The nebulizer devices market size is expected to reach USD 1.62 billion in 2028.

    The automotive fuel systems market was estimated at USD 1.13 billion in 2022.

    The nebulizer devices market is expected to grow at an impressive CAGR of 6% in the coming years.

    Nebulizers are respiratory drug delivery therapeutic device that helps to transform the liquid drug into aerosols or mist and delivers it directly to the lungs. The nebulization technique is commonly used to treat respiratory diseases such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). These devices are electrically powered and rechargeable. Nebulizers are specifically used to deliver liquid medication to breathing passage, thus reducing the bulging of the mucous membrane caused by pollutants.

    Agilent Technologies, Inc. (The U.S), Allied Healthcare Products, Inc. (The U.S), CareFusion Corporation (The U.S), Covidien plc (Ireland), GE Healthcare (The U.S), GF Health Products Inc. (The U.S), Omron Healthcare, Inc. (Japan), PARI GmbH (Germany), Koninklijke Philips N.V. (Netherlands) and Briggs Healthcare (The U.S) are among the key players in the market.

    The North American market garnered the highest market share of more than 25% in 2022

    A rise in environmental pollution and a surge in the number of smokers, rising of chronic respiratory diseases, the growing geriatric population, and increasing demand for home-based healthcare devices are the factors driving the growth of the market.

    Nebulizer devices companies, Hospitals, R&D organizations, Respiratory devices manufacturing companies, and Government organizations are the target audience in the market.